Aneurysmal degeneration after peripheral angioplasty is a potentially serious complication. In this case, the patient underwent repeated angioplasty of a prior vein bypass graft utilizing a paclitaxel-coated balloon. He subsequently developed a progressive aneurysmal degeneration, threatening his bypass, which ultimately required an urgent exclusion with a covered stent. This case represents a rare complication of peripheral bypass graft related to percutaneous intervention as well as paclitaxel-coated devices and warns other practitioners of the increased scrutiny and caution one should exercise in the use of such interventions.
TepeGZellerTAlbrechtT, et al.Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–699.
2.
KatsanosKSpiliopoulosSKitrouP, et al.Risks of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systemic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(24): e011245.
3.
MillsJLConteMSMuradMH. Critical review and evidence of implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease. J Vasc Surg. 2019;70(1):3–7.
4.
WerkMLangnerSReinkensmeierB, et al.Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118(13):1358–1365.
5.
VassilevDKaramfiloffKGilR. Aneurysm formation after paclitaxel-eluting balloon angioplasty used to treat coronary artery restenosis after plain old balloon angioplasty—case report and review of the literature. Adv Interv Cardiol. 2015;11,3(41):250–251.
6.
StoneGWEllisSGCannonL, et al.Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294(10):1215–1223.
AfariMTellezAOhSJ, et al.TCT-178 Impact of varying injury severity and multiple treatments on arterial histopathology early after paclitaxel coated balloon treatment of the ileofemoral arteries of domestic swine. JACC. 2012;60e17:B51.
9.
BisdasTBeropoulisEArgyriouA, et al.1-year all-comers analysis of the Eluvia drug-eluting stent for long femoropopliteal lesions after suboptimal angioplasty. J Am Coll Cardiol Intv. 2018;11(10):957–966.
10.
DiamantopoulosAGuptaYZayedH, et al.Paclitaxel-coated balloons and aneurysm formation in peripheral vessels. J Vasc Surg. 2015;62(5):1320–1322.
11.
GarvinRReifsnyderT. Cutting balloon angioplasty of autogenous infrainguinal bypasses: short-term safety and efficacy. J Vasc Surg. 2007;45(4):724–730.
12.
ViveJBoliaA. Aneurysm formation at the site of percutaneous transluminal angioplasty: a report of two cases and review of the literature. Clin Rad. 1992;41:380–383.
13.
GehaniAAAshleySKesterRC, et al.Technical report: aneurysm formation after dynamic catheter assisted balloon angioplasty. Clin Rad. 1990;41(4):283–285.
14.
SchneiderPALairdJRDorosG, et al.Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon. J Am Col Card. 2019;73(20):2550–2563.
